The pharmacotherapy for Lambert-Eaton myasthenic syndrome (LEMS) is with agents that
Select one or more:
A. increase the release of acetylcholine.
B. increase the transmission of acetylcholine across the synapse.
C. decrease the recycle of choline.
D. decrease the action of acetylcholinesterase.
E. increase the breakdown of monoamine oxidase.